{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-093434","form_type":"8-K","ticker":"GPCR","cik":"0001888886","company_name":"Structure Therapeutics Inc.","filed_at":"2024-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.111889+00:00","generated_at":"2026-05-31T07:28:46.320497+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Structure Therapeutics appoints Angus Russell to Board, Audit Committee","bullets":["Angus Russell appointed Class I director effective Aug 26, 2024; term expires at 2027 annual meeting.","Russell joins Audit Committee; Ted Love, M.D. transitioned off the Audit Committee.","Granted option for 75,000 ordinary shares (25,000 ADS) vesting over 36 months.","Annual cash retainers: $45,000 for Board service plus $10,000 for Audit Committee, prorated for 2024.","Board determined Russell independent under Nasdaq standards and meets audit committee requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-093434","json":"https://secwatch.observer/filing/0001104659-24-093434.json","markdown":"https://secwatch.observer/filing/0001104659-24-093434.md","text":"https://secwatch.observer/filing/0001104659-24-093434.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1888886/000110465924093434/0001104659-24-093434-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1888886/000110465924093434/tm2422732d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:28:46.320497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"744266cdb9","claim":"Angus Russell was appointed as Class I director at Structure Therapeutics Inc..","evidence_excerpt":"appointed Angus Russell to the Board, effective August 26, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1888886/000110465924093434/0001104659-24-093434-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}